Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gregg, R. G.
Right arrow Articles by Simantel, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gregg, R. G.
Right arrow Articles by Simantel, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics Pages 411-414

Localization of a non-specific X-linked mental retardation gene, MRX23, to Xq23-q24
Introduction
Results
Discussion
Materials And Methods
   Polymorphic markers
   Linkage mapping
Acknowledgements
References


Localization of a non-specific X-linked mental retardation gene, MRX23, to Xq23-q24

Localization of a non-specific X-linked mental retardation gene, MRX23, to Xq23-q24 Ronald G. Gregg*, Christina Palmer1, Susan Kirkpatrick1 and Amy Simantel

Waisman Center for Mental Retardation and Human Development, University of Wisconsin, Madison, WI 53706, USA and 1Department of Medical Genetics and Pediatrics, University of Wisconsin, Madison, WI 53706, USA

Received October 25, 1995; Revised and Accepted January 4, 1996

More than 100 X-linked mental retardation syndromes have been described. We report the localization of the disease gene, MRX23, in one family to Xq23-24. Affected family members present with non-specific X-linked mental retardation with verbal disability (BDOAS 10, 1-100). MRX23 is tightly linked to the markers DXS1220 (Z = 3.76 at [theta] = 0.1) and DXS424 (Z = 3.9 at [theta] = 0.06). Multipoint linkage analysis, taking five loci (DXS1072-0.07-DXS1220-0.014-MRX23-0.01-DXS424-0.08-DXS1001) at a time, gives a maximum LOD score of 6.7 between these two markers. The next most likely location, between DXS424 and DXS1001 is 120-fold less likely. Haplotype analysis also indicates the most likely location for the disease gene is between DXS1220 and DXS424.

INTRODUCTION

More than 100 X-linked mental retardation (MR) syndromes have been described (reviewed in ref. 1 ). Approximately half of the disease genes have been mapped to specific regions of the X chromosome. Many have been associated with specific diagnostic criteria and are listed as specific entities in McKusick's Mendelian Inheritance in Man (2 ). Some investigators have proposed that certain regions of the X chromosome are enriched for genes responsible for MR (3 ). However, because few of the genes have been mapped to single chromosome bands, this hypothesis remains speculative. In this report we describe the mapping of a gene, MRX23, responsible for a non-specific X-linked MR syndrome in a single large family (family 1, page 53 of ref. 4 ). The disease in this family was first described in 1974 (4 ) and the pedigree updated in 1984 (5 ). We now describe the mapping of the gene responsible for the disease in this family to between DXS1220 and DXS424, at Xq23-q24.

RESULTS

Linkage mapping has been used to localize the gene responsible for a non-specific X-linked MR syndrome. A detailed clinical description of this family has been published elsewhere (4 ,5 ). Affected males have a non-specific X-linked MR. The only distinguishing feature is that affected males have lower verbal IQs than performance IQs. Several of the affected males have performance IQs above 80; however, because of the lower (12.3 points on average) verbal IQs they are considered retarded. Obligate carrier females were considered unaffected; however, IQs were not determined for these individuals. Cytogenetic studies of the affected males in this family failed to detect either gross chromosome rearrangements or microdeletions when analyzed at the 1600 band level. To localize the gene causing this disease a linkage study using probes that detect polymorphisms was undertaken. Because MRX23 is rare, the mutation rate (µ) was assumed to be 0.0001 and the allele frequency 4µ. These estimates are probably high; however, use of rates an order of magnitude lower (or higher) had little effect on our results (data not shown).

DNA samples were obtained from as many potentially informative family members as possible (Fig. 1 ). The same numbering system used previously (5 ) has been retained to allow comparison with the detailed clinical descriptions of various family members. For the initial analyses 23 markers were genotyped on the potentially informative family members. Table 1 presents the two point analyses between the disease gene and the most informative markers tested. Once tentative linkage with DXS1001 was obtained, all available markers in the region also were typed. Two loci, DXS1220 (Z = 3.76 at [theta] = 0.1) and DXS424 (Z = 3.9 at [theta] = 0.06), show the strongest evidence of linkage to MRX23. Weaker evidence for linkage is detected with more distal markers. The order and distance (Kosambi cM) of markers in this region, obtained from the 2D map obtained online from the Washington University server (http://www.genlink.wustl.edu), is: DXS1072-1.3-DXS1105-6.7-DXS1220-2.4-DXS424-7.7-DXS1001-13.4-DXS994. A more recent map, based on STS mapping (6 ) (http://www-genome.wi.mit.edu), inverts markers DXS1072 and DXS1105 relative to the above map. This inversion eliminates several double recombination events from the data set in the family we describe. Therefore, we have combined the data from these two sources and used the following order and distances in the multipoint analyses: DXS1105-1.3-DXS1072-6.7-DXS1220-2.4-DXS424-7.7-DXS1001-13.4-DXS994. LINKMAP analyses using all the markers in Table 1 indicate the most likely location for MRX23 is between DXS1220 and DXS424 with a maximum LOD score of 6.7. The next most likely location, between DXS424 and DXS1001 is 120-fold less likely. For all other intervals the odds were at least 10 000-fold less likely than between DXS1220 and DXS424. The genotypes of selected family members are shown in Figure 1 . Several females (IV-8,10; V-6,12,22) who did not have affected male offspring also were genotyped. To conserve confidentiality the genotypes of these individuals are not shown. However, the inclusion of these individuals frequently allowed the genotypes of key males, and therefore phase in their female offspring, to be inferred. Two recombination events (arrows, Fig. 1 ), in phase known females V-3 and V-16, detected in males VI-5 and VI-25, respectively, also indicate the disease gene is located between DXS1220 and DXS424.


Figure 1. Partial pedigree of family with non-specific mental retardation, MRX23. Samples were obtained from all living individuals in this pedigree. Black symbols denote affected individuals, unfilled symbols denote unaffected individuals and slashed symbols deceased individuals. Solid vertical lines represent phase known. Genotype data in brackets were inferred from offspring. The arrows show the location of the recombination events that define the minimal location of the disease gene. The double arrowhead indicates that a recombination is likely to have occurred in one of these two males. Pedigree numbering from the original descriptions (4,5) of this family are retained.

DISCUSSION

The gene that causes MRX23, a non-specific mental retardation syndrome has been localized to Xq23-q24, between DXS1220 and DXS424. These two markers are 2.4 cM apart and at this time the physical map of the region has not been completed. When new markers between DXS1220 and DXS424 are identified, the two recombination events detected in individuals VI-5 and VI-25, should allow further refinement of the position of MRX23. This is the first disease to be mapped to this interval and at this time there are no candidate genes in the region. However, the markers DXS1220 and DXS424 are extremely useful for carrier testing and they could be used for prenatal diagnosis if needed. It will be of great interest to test new markers as they become available and eventually to identify candidate genes that are localized to this region of the X chromosome. Because of the differential effects of this mutation on the performance versus verbal IQs of affected males, it will be of interest to characterize this gene, determine its function and compare it with other genes that produce speech delay (7 -9 ).

MATERIALS AND METHODS

Polymorphic markers

The X-chromosome probe detecting the RFLP at DXS52 was obtained from J. L. Mandel. Information regarding microsatellite markers was obtained online from the Genome Database (GDB) (10 ). Primers used to detect the microsatellite markers were purchased either from Research Genetics (Huntsville, AL: DXS1220, DXS996, DXS987, DXS989, DXS992, DXS997, DXS988, DXS1111, DXS1106, DXS1105, DXS1072, DXS1001, DXS994, DXS984) or were synthesized using an Applied Biosystems 380A synthesizer, at the University of Wisconsin Biotechnology Center (KAL, DMD45 and DMD50, SYN1, DXS458, DXS178, DXS424, DXS425, DXS737, HPRT, DXS102, DXS297 and DXS1113).

Table 1 . Pairwise LOD scores (Z) between MRX23 and X-linked loci
 

Recombination fraction ([Theta])

 

 

 

 

 

Zmax

[Theta]max

Locus

0.0

0.05

0.10

0.2

0.3

0.4

 

DXS996

1.41

1.27

1.13

0.83

0.50

0.19

1.41

0.0

KAL

-[infinity]

-3.48

-1.68

-0.26

0.22

0.25

0.25

0.4

DXS987

-[infinity]

-1.36

0.05

0.97

1.04

0.67

1.06

0.27

DXS989

-[infinity]

-1.47

-0.27

0.58

0.72

0.50

0.72

0.29

DXS992

-[infinity]

-3.80

-1.97

-0.46

0.11

0.22

0.22

0.40

DXS997

-[infinity]

-4.11

-2.25

-0.69

-0.08

0.10

0.10

0.40

DMD

-[infinity]

-2.76

-1.43

-0.32

0.10

0.17

0.17

0.40

SYN1

-[infinity]

-0.53

0.16

0.60

0.60

0.38

0.63

0.25

DXS988

-[infinity]

-2.85

-1.52

-0.44

-0.04

0.06

0.06

0.40

DXS1111

-[infinity]

-5.01

-2.85

-1.0

-0.22

0.06

0.06

0.40

DXS458

-[infinity]

-1.83

-1.02

-0.32

-0.03

0.05

0.05

0.40

DXS178

-[infinity]

-2.15

-0.91

0.02

0.30

0.26

0.32

0.33

DXS1106

-[infinity]

-2.15

-0.91

0.02

0.29

0.25

0.32

0.33

DXS1072

-[infinity]

2.25

2.47

2.24

1.69

0.92

2.49

0.13

DXS1105

-[infinity]

-1.14

-0.21

0.43

0.51

0.34

0.51

0.28

DXS1220

-[infinity]

3.63

3.76

3.31

2.47

1.34

3.76

0.10

DXS424

-[infinity]

3.53

3.90

3.76

3.11

2.23

3.92

0.06

DXS1001

-[infinity]

3.32

4.25

4.24

3.54

2.46

4.41

0.07

DXS425

-[infinity]

-1.27

0.27

0.46

0.60

0.43

0.60

0.30

DXS737

-[infinity]

-0.15

0.31

0.60

0.57

0.36

0.63

0.24

DXS994

-[infinity]

1.47

1.78

1.75

1.37

0.78

1.87

0.15

HPRT

-[infinity]

1.50

1.78

1.70

1.30

0.73

1.85

0.14

DXS984

-[infinity]

0.39

0.79

0.95

0.80

0.47

0.95

0.20

DXS102

-[infinity]

1.21

1.52

1.48

1.15

0.64

1.61

0.15

DXS297

-[infinity]

-0.39

0.29

0.70

0.67

0.41

0.74

0.24

DXS1113

-[infinity]

-1.94

-0.50

0.51

0.71

0.50

0.71

0.30

DXS52

-[infinity]

-3.04

-1.53

-0.35

0.03

0.09

0.09

0.40

DNA was isolated from either peripheral blood lymphocytes or lymphoblastoid cell lines by standard methods (11 ). For Southern blots DNA (5 µg) was digested with restriction enzymes for 6-12 h using 5-10 units/µg of DNA, under conditions recommended by the manufacturer. Agarose gel electrophoresis in TAE buffer, hybridization and autoradiography were done using standard methods (12 ). DNA was transferred to Zetabind Nylon membrane in 0.4 N NaOH (13 ). Probes were labeled by the random prime method (14 ) using [32P]-dCTP as the radiolabeled nucleotide.

Microsatellite markers were analyzed as previously described (15 ) using the polymerase chain reaction (PCR) (16 ). Each reaction contained 100-250 ng of genomic DNA, 200 µM of each deoxynucleotide triphosphate, 1 µM of each of the primers, 50 mM KCl, 1.5 mM MgCl2, 10 mM Tris-HCl, pH 8.3, 0.001% gelatin and 0.375 U of Taq DNA polymerase (Perkin-Elmer/Cetus) in a final volume of 15 µl. The DNA was denatured for 2 min at 94oC, followed by 30 cycles of amplification with each cycle consisting of 45 s at 94oC, 1 min at the appropriate annealing temperature (determined empirically), and 2 min at 72oC. One of the primers was 5' end labeled with 32P using polynucleotide kinase (Promega Inc., Madison, WI). The radio- labeled PCR products were mixed with an equal volume of dye mix (90% formamide, 10 mM EDTA, 0.1% w/v xylene cyanol, 0.1% w/v bromophenol blue) heated to 70oC for 2 min and 2.5 µl of this mixture was separated on a 6% denaturing sequencing gel. DNA fragments were visualized by autoradiography.

Linkage mapping

Linkage analyses were done using the VAX versions of the LINKAGE (V5.1) computer programs (17 ). Many of the markers analyzed have multiple alleles; however, in the analyses, only the number present in the pedigree (at most four) were included in the linkage analyses. This simplification has been shown to affect the outcome of the analyses when the genotype of key individuals is unknown (18 ). Because of the highly informative nature of the markers used in this study the genotype of many individuals for whom DNA samples were not available could be inferred, minimizing the effect of this error on the data set.

ACKNOWLEDGMENTS

We wish to thank the family members who donated blood, and many physicians who obtained blood samples, thus making the study possible. Financial support was provided by a grant from The Arc, a national organization for the study of mental retardation.

REFERENCES

1 Neri, G., Chiurazzi, P., Arena, C.J. and Lubs, H.A. (1994) XLMR genes: Update 1994. Am. J. Med. Genet. 51, 542-549. MEDLINE Abstract

2 McKusick, V.A. (1994) Mendelian inheritance in man, 11th edn. Baltimore, Johns Hopkins University Press.

3 Schwartz, C.E., Lubs, H.A., Arena, J.F. and Stevenson, R.E. (1991) In Racagni, G.(ed.), Biological Psychiatry. New York, Elsevier Science, 481-484.

4 Lehrke, R.G. (1974) X-linked mental retardation and verbal disability. BDOAS 10, 1-100.

5 Howard-Peebles, P.N. and Roberts, S.F. (1984) X-linked mental retardation revisited. Am. J. Med. Genet. 17, 95-99. MEDLINE Abstract

6 Hudson, T.J., Stein, L.D., Gerety, S.S., Ma, J., Castle, A.B., Silva, J., Slonim, D.K., Baptista, R., Kruglyak, L., Xu, S-H., Hu, X., Colbert, A.M.E., Rosenberg, C., Reeve-Daly, M.P., Rozen, S., Hui, L., Wu, X., Vestergaard, C., Wilson, K.M., Bae, J.S., Maitra, S., Ganiatsas, S., Evans, C.A., DeAngelis, M.M., Ingalls, K.A., Nahf, R.W., Horton Jr., L.T., Anderson, M.O., Collymore, A.J., Ye, W., Kouyoumjian, V., Zemsteva, I.R., Tam, J., Devine, R., Courtney, D.F., Renaud, M.T., Nguyen, H., O'Conner, T.J., Fizames, C., Fauré, S., Gyapay, G., Dib, C., Morissette, J., Orlin, J.B., Birren, B.W., Goodman, N., Weissenbach, J., Hawkins, T.L., Foote, S., Page, D.C. and Lander, E.S. (1995) An STS-based map of the human genome. Science 270, 1945-1954. MEDLINE Abstract

7 Arveiler, B., Alembik, Y. and Hanauer, A. (1988) Linkage analysis suggests at least two loci for X-linked non-specific mental retardation. Am. J. Med. Genet. 30, 473-483. MEDLINE Abstract

8 Yarbrough, K.M. and Howard-Peebles, P.N. (1976) X-linked non specific mental retardation. Report of a large kindred. Clin. Genet. 9, 125-130. MEDLINE Abstract

9 Gedeon, A.K., Keinänen, M., Adès, L.C., Kääriainen, H., Gécz, J., Baker, E., Sutherland, G.R. and Mulley, J.C. (1995) Overlapping submicroscopic deletions in Xq28 in two unrelated boys with developmental disorders: Identification of a gene near FRAXE. Am. J. Hum. Genet. 56, 907-914. MEDLINE Abstract

10 Fasman, K.H., Cuticchia, A.J. and Kingsbury, D.T. (1994) The GDB(TM) Human Genome Data Base anno 1994. Nucleic Acids Res. 22, 3462-3469. MEDLINE Abstract

11 Bell, G.I., Karam, J.H. and Rutter, W.J. (1981) Polymorphic DNA region adjacent to the 5' end of the human insulin gene. Proc. Natl Acad. Sci. USA. 78, 5759-5763. MEDLINE Abstract

12 Sambrook, J., Fritsch, E.E. and Maniatis, T. (1989) Molecular Cloning. A laboratory manual, 2nd edn. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.

13 Reed, K.C. and Mann, D.A. (1985) Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res. 13, 7207-7221. MEDLINE Abstract

14 Feinberg, A.P. and Vogelstein, B. (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13. MEDLINE Abstract

15 Powers, P.A., Gregg, R.G., Lalley, P., Liao, M. and Hogan, K. (1991) Assignment of the human gene for the [alpha]1-subunit of the cardiac DHP-sensitive Ca2+ channel to chromosome 12p12-pter. Genomics 10, 835-839. MEDLINE Abstract

16 Sakai, R.K., Scharf, S., Faloona, F., Mullis, K.B., Horn, G.T., Erlich, H.A. and Arnheim, N. (1985) Enzymatic amplification of [beta]-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230, 1350-1354.

17 Lathrop, G.M. and Lalouel, J.M. (1984) Easy calculation of lod scores and genetic risks on small computers. Am. J. Hum. Genet. 36, 460-465. MEDLINE Abstract

18 Freimer, N.B., Sandkuijl, L.A. and Blower, S.M. (1993) Incorrect specification of marker allele frequencies: Effects on linkage analysis. Am. J. Hum. Genet. 52, 1102-1110. MEDLINE Abstract


*To whom correspondence should be addressed at: 707 Waisman Center, 1500 Highland Avenue, Madison, WI 53706, USA


This page is maintained by OUP admin. Last updated Thu Oct 31 15:22:29 GMT 1996. Part of the OUP Journals World Wide Web service.Copyright Oxford University Press, 1996


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Med. Genet.Home page
I Meloni, F Vitelli, L Pucci, R B Lowry, R Tonlorenzi, E Rossi, M Ventura, G Rizzoni, C E Kashtan, B Pober, et al.
Alport syndrome and mental retardation: clinical and genetic dissection of the contiguous gene deletion syndrome in Xq22.3 (ATS-MR)
J. Med. Genet., May 1, 2002; 39(5): 359 - 365.
[Full Text] [PDF]


Home page
J Child NeurolHome page
E. Searcy, L. Burd, J. Kerbeshian, A. Stenehjem, and L. A. Franceschini
Asperger's Syndrome, X-Linked Mental Retardation (MRX23), and Chronic Vocal Tic Disorder
J Child Neurol, October 1, 2000; 15(10): 699 - 702.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Sloan and S. Mager
Cloning and Functional Expression of a Human Na+ and Cl--dependent Neutral and Cationic Amino Acid Transporter B0+
J. Biol. Chem., August 20, 1999; 274(34): 23740 - 23745.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
H. E. Steingruber, A. Dunham, A. J. Coffey, S. M. Clegg, G. R. Howell, G. L. Maslen, C. E. Scott, R. Gwilliam, P. J. Hunt, E. C. Sotheran, et al.
High-Resolution Landmark Framework for the Sequence-Ready Mapping of Xq23-q26.1
Genome Res., August 1, 1999; 9(8): 751 - 762.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gregg, R. G.
Right arrow Articles by Simantel, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gregg, R. G.
Right arrow Articles by Simantel, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?